Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	47.01	46.98	47.64	48.14	5.45
Cash & Cash Equivalents	47.01	46.98	47.64	48.14	5.45
Cash Growth	0.06%	-1.38%	-1.04%	783.99%	-16.22%
Receivables	0	0	0.03	0.03	0.49
Other Current Assets	0.33	0.41	0.09	0.06	0.06
Total Current Assets	47.34	47.39	47.75	48.23	5.99
Other Long-Term Assets	0.36	0.2	0	0	0.49
Total Long-Term Assets	0.36	0.2	0	0	0.49
Total Assets	47.7	47.59	47.75	48.23	6.48
Accounts Payable	0.33	0.33	0.33	0.3	0.32
Other Current Liabilities	1.38	1.37	0.07	0.11	0.1
Total Current Liabilities	1.71	1.7	0.4	0.41	0.42
Other Long-Term Liabilities	42.48	42.48	42.48	40.46	0
Total Long-Term Liabilities	42.48	42.48	42.48	40.46	0
Total Liabilities	1.71	1.7	0.4	0.41	0.42
Common Stock	0.74	0.74	0.74	0.74	0.44
Retained Earnings	-70.67	-72.04	-71.86	-71.39	-70.08
Comprehensive Income	-1.28	0	0	0	0
Shareholders' Equity	45.99	45.89	47.35	47.82	6.06
Total Liabilities and Equity	47.7	47.59	47.75	48.23	6.48
Net Cash / Debt	47.01	46.98	47.64	48.14	5.45
Net Cash / Debt Growth	0.06%	-1.38%	-1.04%	783.99%	-16.22%
Net Cash Per Share	0.63	0.63	0.64	0.94	0.12
Working Capital	45.63	45.69	47.35	47.82	5.57
Book Value Per Share	0.62	0.62	0.64	0.94	0.14

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.